These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 14592908)

  • 1. The epidemiology of myasthenia gravis.
    Phillips LH
    Ann N Y Acad Sci; 2003 Sep; 998():407-12. PubMed ID: 14592908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of myasthenia gravis.
    Phillips LH
    Semin Neurol; 2004 Mar; 24(1):17-20. PubMed ID: 15229788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996.
    Zivadinov R; Jurjevic A; Willheim K; Cazzato G; Zorzon M
    Neuroepidemiology; 1998; 17(5):265-72. PubMed ID: 9705586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of myasthenia gravis in Ontario, Canada.
    Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
    Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epidemiology of Myasthenia Gravis in Korea.
    Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
    Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prevalence of myasthenia gravis in the United States: A claims-based analysis.
    Rodrigues E; Umeh E; Aishwarya ; Navaratnarajah N; Cole A; Moy K
    Muscle Nerve; 2024 Feb; 69(2):166-171. PubMed ID: 38040629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of myasthenia gravis].
    Pekmezović T; Lavrnić D; Jarebinski M; Apostolski S
    Srp Arh Celok Lek; 2006; 134(9-10):453-6. PubMed ID: 17252917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Myasthenia Gravis in Sweden 2006-2016.
    Westerberg E; Punga AR
    Brain Behav; 2020 Nov; 10(11):e01819. PubMed ID: 32869520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic evidence for a changing natural history of myasthenia gravis.
    Phillips LH; Torner JC
    Neurology; 1996 Nov; 47(5):1233-8. PubMed ID: 8909435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of myasthenia gravis.
    Phillips LH
    Neurol Clin; 1994 May; 12(2):263-71. PubMed ID: 8041341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of myasthenia gravis in the Catalan county of Osona.
    Aragonès JM; Altimiras J; Roura P; Alonso F; Bufill E; Munmany A; Alfonso S; Illa I
    Neurologia; 2017; 32(1):1-5. PubMed ID: 25449965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
    Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
    Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
    Niks EH; Kuks JB; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey.
    Somnier FE; Keiding N; Paulson OB
    Arch Neurol; 1991 Jul; 48(7):733-9. PubMed ID: 1859301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden.
    Kalb B; Matell G; Pirskanen R; Lambe M
    Neuroepidemiology; 2002; 21(5):221-5. PubMed ID: 12207149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of myasthenia gravis in northwestern Sardinia.
    Aiello I; Pastorino M; Sotgiu S; Pirastru MI; Sau GF; Sanna G; Rosati G
    Neuroepidemiology; 1997; 16(4):199-206. PubMed ID: 9267837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of myasthenia gravis in the province of Trento (northern Italy).
    Ferrari G; Lovaste MG
    Neuroepidemiology; 1992; 11(3):135-42. PubMed ID: 1407249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of myasthenia gravis in Norway.
    Storm-Mathisen A
    Acta Neurol Scand; 1984 Oct; 70(4):274-84. PubMed ID: 6507037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.